Biomimix Stock Revenue
Biomimix fundamentals help investors to digest information that contributes to Biomimix's financial success or failures. It also enables traders to predict the movement of Biomimix Pink Sheet. The fundamental analysis module provides a way to measure Biomimix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomimix pink sheet.
Biomimix |
Biomimix Company Revenue Analysis
Biomimix's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Biomimix Revenue | 34.76 K |
Most of Biomimix's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomimix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Biomimix reported 34.76 K of revenue. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Biomimix Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomimix's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biomimix could also be used in its relative valuation, which is a method of valuing Biomimix by comparing valuation metrics of similar companies.Biomimix is currently under evaluation in revenue category among its peers.
Biomimix Fundamentals
| Return On Asset | -62.76 | |||
| Operating Margin | (495.03) % | |||
| Current Valuation | 533.92 K | |||
| Shares Outstanding | 40.11 M | |||
| Price To Earning | (0.80) X | |||
| Price To Sales | 4.62 X | |||
| Revenue | 34.76 K | |||
| Gross Profit | 26.59 K | |||
| Net Income | (182.45 K) | |||
| Cash And Equivalents | 893 | |||
| Total Debt | 374.37 K | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (3.84 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -1.31 | |||
| Market Capitalization | 160.44 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Biomimix Pink Sheet
If you are still planning to invest in Biomimix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biomimix's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |